NYSE · Medical - Diagnostics & Research

Agilent Technologies, Inc. (A) Stock

$170.54 +1.41% NYSE: A Healthcare

Valuation

MetricValue
Price$170.54
Market Cap$48.17B
P/E Ratio33.95
P/B Ratio6.62
P/S Ratio6.62
EPS (TTM)$4.57
52-Week High$176.95
52-Week Low$108.35
Dividend Yield0.59%

Financials & Margins

MetricValue
ROE20.47%
ROA10.31%
ROCE14.03%
Gross Margin21.29%
Operating Margin21.29%
Net Margin19.53%
Debt/Equity0.54
Current Ratio1.96

Annual Financials (USD)

Metric20212022202320242025
Revenue$6.3B$6.8B$6.8B$6.5B$6.9B
Operating Profit$1.3B$1.6B$1.4B$1.5B$1.5B
Net Profit$1.2B$1.3B$1.2B$1.3B$1.3B
EPS$3.94$4.18$4.19$4.43$4.57
Op Margin21.3%23.6%19.8%22.9%21.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$10.7B$10.5B$10.8B$11.8B$12.7B
Total Liabilities$5.3B$5.2B$4.9B$5.9B$6.0B
Cash$1.5B$1.1B$1.6B$1.3B$1.8B
Borrowings$2.7B$2.8B$2.7B$3.6B$3.4B

Latest News

Agilent Strengthens Biopharma Growth Prospects With AI Expansion Zacks · Jul 9, 2026 Is Agilent Technologies, Inc. (A) Stock Positioned for Growth as Life Sciences Sector Trends Stabilize? Insider Monkey · Jul 8, 2026 Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis Business Wire · Jul 8, 2026 Agilent (A) Stock Looks Below Fair Value On Cash Flow Simply Wall St. · Jul 7, 2026 Surplus Solutions, an NMS Capital Portfolio Company, Accelerates Technical Service Capabilities; Announces Partnership with DCM BioServices PR Newswire · Jul 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$1.5B$1.3B$1.8B$1.8B$1.6B
Investing Cash Flow$-938.0M$-629.0M$-608.0M$-1.6B$-801.0M
Financing Cash Flow$-816.0M$-1.1B$-630.0M$-1.1B$-464.0M
Net Cash Flow$43.0M$-434.0M$537.0M$-261.0M$459.0M
Free Cash Flow$1.3B$1.0B$1.5B$1.4B$1.2B

Valuation & Return Ratios

MetricValue
PEG Ratio1.79
EV / EBITDA25.90
FCF Yield2.94%
Quick Ratio1.56
Interest Coverage15.46
Return 1Y22.63%
Return 3Y53.93%
Return 5Y15.36%

Ownership

Insiders Held0.19%
Institutions Held94.06%
Institutions Float Held94.24%
Institutional HolderSharesReport Date
Blackrock Inc.25,902,6622026-03-31
Vanguard Capital Management LLC18,381,0302026-03-31
Vanguard Portfolio Management LLC14,352,6822026-03-31
State Street Corporation12,764,6322026-03-31
Massachusetts Financial Services Co.12,624,0902026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BIOBio-Rad Laboratories, Inc. $366.16 +1.60% 44.31 $9.86B 0.00%
BRKRBruker Corporation $58.84 +1.59% -91.36 $8.96B 0.31%
DHRDanaher Corporation $219.87 +1.11% 39.76 $154.57B 0.71%
MTDMettler-Toledo International, Inc. $1549.99 +1.34% 31.26 $31.32B 0.00%
QGENQiagen N.V. $45.38 +1.91% 22.95 $9.36B 1.56%

About Agilent Technologies, Inc.

Agilent Technologies, Inc. is led by CEO Padraig McDonnell, employs 17,900 people, headquartered in Santa Clara, US, publicly traded since 1999.

Agilent Technologies, Inc. (A) stock trades at $170.54 with a market capitalization of $48.17B. The stock is valued at a price-to-earnings (P/E) ratio of 33.95, price-to-book of 6.62, price-to-sales of 6.62. Over the past 52 weeks the stock has ranged between $108.35 and $176.95, and currently trades 3.6% below its 52-week high. It pays a dividend yielding 0.59%.

On profitability, Agilent Technologies, Inc. generates a return on equity (ROE) of 20.47% — well above the market average, a sign of a high-quality business, return on capital employed of 14.03%, an operating margin of 21.29%, a net profit margin of 19.53%.

In its most recent fiscal year, Agilent Technologies, Inc. reported annual revenue of $6.9B, net profit of $1.3B, revenue has compounded at 5.4% a year over the last five years, profit at 12.6% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 0.54, a current ratio of 1.96, total assets of $12.7B, $1.8B in cash and equivalents.

A has a beta of 1.24.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides